Form 4: Trulieve President Granted Significant Equity Awards

Trulieve Cannabis Corp. President Jason Pernell received grants of 58,594 restricted stock units and 41,668 stock options.

Summary

• President Jason Pernell was granted 58,594 restricted stock units (RSUs) on March 13, 2026, each representing a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share.
• The RSUs will vest in two tranches: 50% on December 1, 2027, and the remaining 50% on December 1, 2028.
• An additional 41,668 stock options were granted on March 13, 2026, with an exercise price of $6.4 per share and an expiration date of March 13, 2033.
• These stock options will vest in three annual installments: one-third on December 1, 2026, one-third on December 1, 2027, and one-third on December 1, 2028.
• Following these transactions, Jason Pernell beneficially owns 581,795 subordinate voting shares (including the new RSU grant) and 41,668 derivative securities (stock options).
• Pernell also holds 22,635 Multiple Voting Shares through the JASON B PERNELL TR KFP IRREVOCABLE TRUST DTD 03/02/2020 and 22,636 Multiple Voting Shares through the KATHRYN FIELD PERNELL & TY ROOFNER TR JBP 2020 IRREVOCABLE TRUST DTD 01/06/2020, which are convertible into an aggregate of 4,527,100 Subordinate Voting Shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, as it aligns the President's long-term interests with the company's performance through significant equity awards, which is a standard and healthy practice for executive retention and motivation.

Positives

• The equity grants align the President's long-term financial interests with those of Trulieve Cannabis Corp. shareholders, incentivizing sustained company performance.
• The multi-year vesting schedules for both RSUs and stock options promote executive retention and focus on long-term strategic goals.

Negatives

• Future dilution of existing shareholder equity will occur upon the vesting and exercise of these equity awards, which is a standard aspect of equity compensation.

Risks

• The potential for future dilution of existing shareholder equity upon the vesting and exercise of the granted restricted stock units and stock options.

Future Outlook

The filing details future vesting schedules for restricted stock units and stock options, indicating a long-term incentive structure for the President, with vesting events scheduled through December 2028 and option expiration in March 2033.

Industry Context

StockSavvy.ai notes that equity grants are a common form of executive compensation across industries, including the rapidly evolving cannabis sector, used to attract, retain, and incentivize key personnel by aligning their financial success with the company's performance.

Comparison to Industry Standards

• StockSavvy.ai observes that multi-year vesting schedules for both restricted stock units and stock options are standard practice for executive compensation in publicly traded companies, aligning executive interests with long-term shareholder value. This structure is consistent with typical compensation packages seen in established companies across various sectors.

Related Party Transactions

• The reporting person, Jason Pernell, is deemed to exercise voting and investment control over Multiple Voting Shares held by the JASON B PERNELL TR KFP IRREVOCABLE TRUST DTD 03/02/2020 and the KATHRYN FIELD PERNELL & TY ROOFNER TR JBP 2020 IRREVOCABLE TRUST DTD 01/06/2020. These are existing holdings and not new transactions detailed in this filing.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through incentivized management, balanced against future dilution from equity awards.
• Employees (specifically the President): Receives significant long-term equity compensation, aligning personal financial success with company performance.

Next Steps

• Vesting of 50% of restricted stock units on December 1, 2027.
• Vesting of the remaining 50% of restricted stock units on December 1, 2028.
• Vesting of one-third of stock options on December 1, 2026.
• Vesting of one-third of stock options on December 1, 2027.
• Vesting of one-third of stock options on December 1, 2028.
• Expiration of stock options on March 13, 2033.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a key executive, which is a standard practice for aligning management incentives with shareholder value. It does not present new information that would significantly alter the investment thesis for Trulieve Cannabis Corp., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Trulieve Cannabis, TRUL, SEC Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Jason Pernell, Cannabis Industry